Taimei Technology and C&R Research Announce Strategic Partnership to Build AI-Powered Clinical Trial Innovation

About this update from Zhejiang Taimei Medical Technology Co Ltd Class H

[{"type":"text","content":"SEOUL, South Korea and SHANGHAI, May 7, 2026 /PRNewswire/ -- Taimei Technology (HK.02576), a leading AI-powered drug clinical development platform company, and C&R Research (A359090), a top-tier CRO in South Korea, signed an enterprise-level strategic partnership agreement, officially launching the development of an AI-based clinical trial operations system.","length":369,"tagName":"p"},{"type":"image","alt":"Scene from the signing of the strategic cooperation agreement.","displaySize":"","headline":null,"caption":"Scene from the signing of the strategic cooperation agreement.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":243,"url":"https://media.zenfs.com/en/prnewswire.com/2858840beef42b065146392481bbdb77"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Zq3HV.o4VJdOQOVxQmmfdg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQyOA--/https://media.zenfs.com/en/prnewswire.com/2858840beef42b065146392481bbdb77","width":400,"height":243},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/V1NgQItIVK8PY4NlXo2BSw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTM4OQ--/https://media.zenfs.com/en/prnewswire.com/2858840beef42b065146392481bbdb77","width":400,"height":243}},"href":"https://mma.prnewswire.com/media/2970069/image1.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Under this partnership, C&R Research will deploy Taimei Technology's leading digital infrastructure and AI Agents across multiple clinical trials to automate and enhance trial design and operational workflows. A particular focus will be on data management, where the EDC + iDM Agent combination will be actively adopted. Innovations such as intelligent data capture and governance, AI-driven eCRF generation, and automated test case creation are expected to boost productivity and quality in clinical research.","length":518,"tagName":"p"},{"type":"text","content":"Leveraging its full-stack AI capabilities, 13 years of industry expertise, and global operational experience, Taimei Technology has deeply focused on the clinical research vertical, and has been among the first to build a comprehensive AI Agent matrix, enabling scenario-based AI applications across the entire clinical research workflow. Key offerings include eCollect (EDC), eBalance (RTSM), eCOA, eCooperate (CTMS), and eArchives (eTMF), iDM Agent, iCTA Agen...

More updates from Zhejiang Taimei Medical Technology Co Ltd Class H